PRAX News and Press, Praxis Precision Medicines Inc. From 12/09/25

Clear recognition of high unmet need and urgency for the SCN2A community and plausibility of the mechanism of elsunersen FDA agreed to proposed changes to the EMBRAVE3 trial design to be a single-arm, baseline-controlled study Enrollment in EMBRAVE3 is quickly accelerating and...

2025-12-09 12:06:21 ET from Jefferies issued a price target of $450.00 for PRAX on 2025-12-09 16:01:12. The adjusted price target was set to $450.00. At the time of the announcement, PRAX was trading at $264.395. The overall price target consensus is at $388.80 with high...

A look at the top 10 most actives in the United States Paranovus Entertainment Technology Ltd. (PAVS) rose 33.6% to $0.0489 on volume of 1,320,857,302 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 2.7% to $2.93 on volume of 288,725,865 shares NVIDIA Corporation (NVDA) rose ...

A look at the top 10 most actives in the United States Paranovus Entertainment Technology Ltd. (PAVS) rose 28.7% to $0.0471 on volume of 1,267,429,086 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 1.3% to $2.9699 on volume of 260,909,941 shares NVIDIA Corporation (NVDA) ros...

2025-12-08 10:06:22 ET from Truist Financial issued a price target of $500.00 for PRAX on 2025-12-08 14:19:55. The adjusted price target was set to $500.00. At the time of the announcement, PRAX was trading at $273.11. The overall price target consensus is at $352.00 wit...

A look at the top 10 most actives in the United States Paranovus Entertainment Technology Ltd. (PAVS) rose 16.2% to $0.0366 on volume of 1,054,633,808 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 3.5% to $3.01 on volume of 300,156,120 shares Warner Bros. Discovery Inc. (WB...

Positive Results in the EMBOLD study of relutrigine showed a 53% placebo-adjusted reduction in seizures (p < 0.0002), 66% increase in motor seizure-free days (p = 0.0340), broad and clinically meaningful functional improvements (p ≤ 0.002) Patients in the RADIANT study of ...

A look at the top 10 most actives in the United States Paranovus Entertainment Technology Ltd. (PAVS) rose 17.5% to $0.037 on volume of 1,002,607,027 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 4.3% to $2.985 on volume of 267,033,397 shares Warner Bros. Discovery Inc. (WB...

2025-12-05 14:39:23 ET Investment Overview - Praxis Caps Off Incredible Year With Another Study Success Read the full article on Seeking Alpha For further details see: Praxis Precision Medicines: Latest Study Wins Sets Up 2 CNS Drug Approvals In 2026

2025-12-05 09:06:32 ET from Deutsche Bank issued a price target of $303.00 for PRAX on 2025-12-05 13:37:32. The adjusted price target was set to $303.00. At the time of the announcement, PRAX was trading at $264.87. The overall price target consensus is at $338.86 with h...